Results 131 to 140 of about 2,408 (176)

Comparison of different LDL apheresis methods

Expert Review of Cardiovascular Therapy, 2008
This article presents the generally accepted indications for LDL apheresis treatment. The available LDL apheresis methods differ with respect to acute relative reductions of LDL cholesterol; mean values after the LDL apheresis treatments are not different. Serum triglycerides, HDL-cholesterol, and lipoprotein(a) are also acutely reduced.
Ulrich, Julius, Antje, Frind, Sergej, Tselmin, Steffi, Kopprasch, Ines, Poberschin, Gabriele, Siegert   +5 more
openaire   +2 more sources

Recommendations for the use of LDL apheresis

Atherosclerosis, 2008
Plasma exchange has been shown to increase life-expectancy in homozygous familial hypercholesterolaemia (FH) but increasingly is being replaced by LDL apheresis. Several methods are now available for undertaking this procedure, which lowers LDL cholesterol and Lp(a) efficiently and safely when performed weekly or bi-weekly and causes only slight ...
openaire   +2 more sources

LDL Apheresis and Inflammation – Implications for Atherosclerosis

Scandinavian Journal of Immunology, 2012
AbstractLow‐density lipoprotein (LDL) apheresis is an extracorporeal treatment modality used in high‐risk patients when LDL cholesterol levels cannot be reduced adequately with medication. The treatment is highly effective, but could be affected by potential unwanted effects on pro‐ and anti‐inflammatory biomarkers.
A, Hovland, K T, Lappegård, T E, Mollnes   +2 more
openaire   +2 more sources

An update on LDL apheresis for nephrotic syndrome

Pediatric Nephrology, 2018
Low-density lipoprotein (LDL) apheresis has been used increasingly in clinical practice for the treatment of renal diseases with nephrotic syndrome (NS), specifically focal segmental glomerulosclerosis (FSGS). Persistent hyperlipidemia for prolonged periods is nephrotoxic and leads to chronic progressive glomerular and tubulointerstitial injury ...
Rupesh Raina, Vinod Krishnappa
openaire   +2 more sources

Activation of coagulation by a LDL-apheresis device

Blood Coagulation & Fibrinolysis, 1996
LDL-apheresis often induces an almost constant and progressive increase of the differential pressure of plasma flowing through the dextran sulphate cellulose column, reducing the efficacy of the treatment. On two occasions we were able to identify a fibrin plug by immunofluorescence. Our aim was to verify the modification of some coagulation indicators
C, Giansante, P, Bordin, N, Fiotti, S, Calabrese, A, Petrucco, P G, Da Col, M, Fonda, L, Cattin   +7 more
openaire   +2 more sources

Role of LDL apheresis in the management of hypercholesterolaemia

Transfusion Science, 1993
Abstract It is now established that extracorporeal cholesterol removal is the best means of improving prognosis in patients with homozygous FH and this should be started before atherosclerosis becomes apparent. Anti-human LDL antibodysepharose columns, dextran sulphate-cellulose gel columns and the HELP system are all potent methods of extracorporeal
Y, Kitano, G R, Thompson
openaire   +2 more sources

Overview: Techniques and Indications of LDL-Apheresis

Biomaterials, Artificial Cells and Immobilization Biotechnology, 1991
In recent years, LDL-apheresis has emerged to be an efficient treatment of hyperlipidemia in patients who do not respond sufficiently to diet and lipid lowering drugs. A survey of LDL lowering extracorporeal procedures is presented. Among them, to date 5 procedures have been used clinically on a routine basis: unselective plasma exchange, semi ...
T, Bosch, H J, Gurland
openaire   +2 more sources

Organization and Technical Problems of LDL-apheresis

The International Journal of Artificial Organs, 1993
The Authors consider problems related to technique and organization of LDL-Apher-esis with respect to some particular aspects. They evaluate: a) Technical complexity of procedures both in devices to use and in staff preparation; b) Length of treatment which conditions the other fields of activity; c)
N, Scarpato, C, Falco, G, Nappi, S, Formisano   +3 more
openaire   +2 more sources

[LDL apheresis: an update and overview. LDL apheresis in Sardinia, Italy (SMILDLa)].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2012
LDL apheresis (LDLa) is an invasive therapeutic tool to control qualitative and quantitative disorders of lipid metabolism. It is aimed at achieving a metabolic balance in association with lipid-lowering drugs in patients with severe, genetically determined or acquired dyslipidemia who do not reach clinically adequate LDL-cholesterol (LDL-C) levels (
Claudia, Stefanutti, Serafina, Di Giacomo, Claudia, Morozzi   +2 more
openaire   +1 more source

LDL apheresis as it relates to nursing practice

Transfusion and Apheresis Science, 2017
Nurses are an essential partner in the treatment of complex diseases and they have extensive influence on patient outcomes. Connecting a patient to a machine takes courage, skill, and a whole lot of trust. Anyone who has earned the title of "nurse" has shown courage. Skill comes with hours and hours of practice. Trust is earned and ongoing.
openaire   +2 more sources